Onderneming Dr. Reddy's Laboratories Limited Nyse
Aandelen
RDY
US2561352038
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
78,47 USD | -2,45% |
|
+1,02% | +12,78% |
Vakgebied
- verkoop van generieke geneesmiddelen (79,9%): merknaam of generieke geneesmiddelen op recept en OTC-geneesmiddelen;
- verkoop van actieve ingrediënten (15,7%). De groep levert ook farmaceutische diensten op maat;
- overige (4,4%): verkoop van generieke biofarmaceutische producten, ontwikkeling van moleculaire middelen, enz.
De netto-omzet is geografisch als volgt verdeeld: India (18,8%), de Verenigde Staten (45%), Rusland (9,9%) en overig (26,3%).
Aantal werknemers: 27 048
Verkoop per activiteit
INR in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Global Generics
87,9
%
| 213 768 | 86,9 % | 245 453 | 87,9 % | +14,82% |
Pharmaceutical Services and Active Ingredients
10,7
%
| 29 069 | 11,8 % | 29 801 | 10,7 % | +2,52% |
Others
1,4
%
| 3 042 | 1,2 % | 3 910 | 1,4 % | +28,53% |
Verkoop per regio
INR in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
United States
48,6
%
| 106 683 | 43,4 % | 135 565 | 48,6 % | +27,07% |
Others
26,1
%
| 67 469 | 27,4 % | 72 825 | 26,1 % | +7,94% |
India
17,4
%
| 50 499 | 20,5 % | 48 473 | 17,4 % | -4,01% |
Russia
8,0
%
| 21 228 | 8,6 % | 22 301 | 8,0 % | +5,05% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02-04-18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02-11-20 |
Chairman | 56 | 18-01-93 | |
Gunupati Prasad
CHM | Chairman | 63 | 08-04-86 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
K. Randhir Singh
CMP | Compliance Officer | - | 17-03-22 |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 01-05-21 |
Deepak Sapra
PRN | Corporate Officer/Principal | - | 01-01-03 |
Archana Bhaskar
HRO | Human Resources Officer | 57 | 01-06-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08-04-86 |
Chairman | 56 | 18-01-93 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 05-06-07 |
Shikha Sharma
BRD | Director/Board Member | 64 | 31-01-19 |
Leo Puri
BRD | Director/Board Member | 63 | 25-10-18 |
Claudio Albrecht
BRD | Director/Board Member | 64 | 10-05-23 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | 29/12 |
Director/Board Member | 64 | 07-01-22 | |
Alpna Seth
BRD | Director/Board Member | 60 | 19-09-23 |
Penny Wan
BRD | Director/Board Member | - | 28-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 166 829 701 | 117 879 796 ( 70,66 %) | 289 791 ( 0,1737 %) | 70,66 % |
Bedrijfsgegevens
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.com![Adres Dr. Reddy's Laboratories Limited(RDY)](https://cdn.zonebourse.com/static/address/14214.png)
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Dr. Reddy's Laboratories SA
![]() Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Aurigene Pharmaceutical Services Ltd.
![]() Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+61,53% | 848 mld. | |
+34,31% | 627 mld. | |
-3,66% | 363 mld. | |
+15,06% | 318 mld. | |
+9,18% | 299 mld. | |
+11,66% | 234 mld. | |
+15,48% | 225 mld. | |
+15,67% | 179 mld. | |
+2,47% | 167 mld. |
- Beurs
- Aandelen
- Koers DRREDDY
- Koers RDY
- Onderneming Dr. Reddy's Laboratories Limited